gc012f
gracell biotechnologies
['gc012f ']
gracell biotechnologies presents updated clinical data for bcma/cd19 dual-targeting fastcar gc012f in rrmm at eha2022 congress, highlighting 100% mrd negativity rate in all treated patients 
https://t.co/r4I5tcWh52